Understanding cognitive variability in adults with Down syndrome and its link to Alzheimer’s disease biomarkers
Official title: Intraindividual cognitive variability in aging adults with Down syndrome: associations with Alzheimer's disease plasma biomarkers, neuropathology and clinical dementia
Funded at Rutgers Biomedical and Health Sciences · NIH-11413879 · Data updated 2026-11-12
A study of adults with Down syndrome to see if everyday ups and downs in thinking tests can predict Alzheimer’s-related changes and dementia using blood and brain biomarkers.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project start | August 15, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2026 |
| Award (this year) | $246,694 |
| NIH project number | 5R00AG082864-04 |
| Project ID | NIH-11413879 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with Down syndrome who are part of or eligible for the ABC-DS dataset, with available cognitive testing and biomarker data.
✕Less likely to help
Individuals without Down syndrome or without access to the ABC-DS data may not directly benefit from this study.
What this research studies
People with Down syndrome have a higher risk of developing Alzheimer’s disease, and this project looks at a new, inexpensive way to flag early dementia by measuring fluctuations in cognitive test results. The researchers will use existing data from the ABC-DS study, analyzing memory, thinking speed, problem solving, and visuospatial skills over two time points to calculate intraindividual cognitive variability. They will then explore how these variability scores relate to blood biomarkers like beta-amyloid and tau, as well as brain imaging markers and clinical dementia symptoms. The goal is to identify a simple predictor that could help enroll suitable individuals in future anti-Alzheimer’s therapies.
Why it matters
Potential benefit: If successful, this could provide a low-cost, non-invasive way to identify DS individuals at higher risk for dementia and guide timely treatment decisions.
How similar studies have gone: This approach is being explored in the general population, with some promise, but its applicability to Down syndrome is still being investigated.
Where this research is happening
-
Rutgers Biomedical and Health Sciences
Newark, United States Active
Researchers
- Principal investigator: Fonseca, Luciana — Rutgers Biomedical and Health Sciences
- Study coordinator: Fonseca, Luciana
Related research
Other NIH-funded projects on the same topics.
-
Thinking variability and Alzheimer's markers in adults with Down syndrome
This project looks at whether ups-and-downs in thinking tests can signal early Alzheimer's in adults with Down syndrome.
-
Understanding cognitive changes in aging adults with Down syndrome and Alzheimer's disease
This study is looking at how differences in thinking skills among adults with Down syndrome might be connected to early signs of Alzheimer's disease, and it's for adults with Down syndrome who want to help us understand more about dementia.
-
Beaver Dam Offspring Study: How midlife senses and aging markers relate to early Alzheimer’s and dementia
This study follows adults who previously participated in a long-term cohort to see if midlife changes in hearing, vision, smell, and aging biomarkers can predict later risk of Alzheimer’s disease and related dementias.
-
Combining aging surveys to understand memory, Alzheimer's, and dementia care
This project brings together long-term survey data from many countries and adds things like air pollution and care-policy information to see how they relate to memory, mild cognitive problems, and Alzheimer's risk in older adults.
-
Midlife memory and dementia risk in Kenyan adults
This work looks at midlife thinking and memory and how childhood health and life experiences might affect future dementia risk for Kenyan adults.
-
Understanding how sensory changes and aging in midlife relate to Alzheimer's and dementia
This project explores how changes in hearing, vision, and smell, along with signs of aging in middle age, might predict the risk of Alzheimer's disease and related dementias later in life.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.